Allostimulation-induced tumor cytotoxic cells: from mouse to man

Giorgio Parmiani, Marialuisa Sensi, Giuseppe Fossati

Research output: Contribution to journalArticle

Abstract

Experimental tumors may express cell surface antigens which cross-react with alloantigens of normal allogeneic tissues1. These may be H-2 or non-H-2 histocompatibility antigens and differentiation antigens1-3. Because of this cross-reactivity animals immunized with allogeneic normal tissues bearing determinants shared by a syngeneic transplantable tumor acquire resistance to the tumor in vivo and lymphocytes specifically cytotoxic to syngeneic tumor cells in vitro. However, in similar experiments tumor cells which did not express detectable amounts of cross-reacting antigens were also rejected in syngeneic animals (mouse and rat) immunized with normal allogeneic tissues4,5. In this instance the mechanism of antitumor rejection could not be clearly established5. In other investigations allostimulation of the mouse lymphocytes in vitro generated cells cytotoxic against syngeneic tumor cells and allostimulation of human lymphocytes generated cells which killed autologous tumor cells6-10. The mechanisms underlying these phenomena differ in detail but in each case the end result is the production of tumor-restricted cytotoxic cells. Here Giorgio Parmiani and his colleagues review these investigations and discuss the possible clinical utility of cytotoxic cells generated in this way.

Original languageEnglish
Pages (from-to)215-218
Number of pages4
JournalImmunology Today
Volume6
Issue number7
DOIs
Publication statusPublished - 1985

Fingerprint

Neoplasms
Lymphocytes
Histocompatibility Antigens
Isoantigens
Surface Antigens
Antigens
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology

Cite this

Allostimulation-induced tumor cytotoxic cells : from mouse to man. / Parmiani, Giorgio; Sensi, Marialuisa; Fossati, Giuseppe.

In: Immunology Today, Vol. 6, No. 7, 1985, p. 215-218.

Research output: Contribution to journalArticle

Parmiani, Giorgio ; Sensi, Marialuisa ; Fossati, Giuseppe. / Allostimulation-induced tumor cytotoxic cells : from mouse to man. In: Immunology Today. 1985 ; Vol. 6, No. 7. pp. 215-218.
@article{c3f5a7997e3948b8b454dd8e7508db9e,
title = "Allostimulation-induced tumor cytotoxic cells: from mouse to man",
abstract = "Experimental tumors may express cell surface antigens which cross-react with alloantigens of normal allogeneic tissues1. These may be H-2 or non-H-2 histocompatibility antigens and differentiation antigens1-3. Because of this cross-reactivity animals immunized with allogeneic normal tissues bearing determinants shared by a syngeneic transplantable tumor acquire resistance to the tumor in vivo and lymphocytes specifically cytotoxic to syngeneic tumor cells in vitro. However, in similar experiments tumor cells which did not express detectable amounts of cross-reacting antigens were also rejected in syngeneic animals (mouse and rat) immunized with normal allogeneic tissues4,5. In this instance the mechanism of antitumor rejection could not be clearly established5. In other investigations allostimulation of the mouse lymphocytes in vitro generated cells cytotoxic against syngeneic tumor cells and allostimulation of human lymphocytes generated cells which killed autologous tumor cells6-10. The mechanisms underlying these phenomena differ in detail but in each case the end result is the production of tumor-restricted cytotoxic cells. Here Giorgio Parmiani and his colleagues review these investigations and discuss the possible clinical utility of cytotoxic cells generated in this way.",
author = "Giorgio Parmiani and Marialuisa Sensi and Giuseppe Fossati",
year = "1985",
doi = "10.1016/0167-5699(85)90037-4",
language = "English",
volume = "6",
pages = "215--218",
journal = "Immunology Today",
issn = "0167-5699",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - Allostimulation-induced tumor cytotoxic cells

T2 - from mouse to man

AU - Parmiani, Giorgio

AU - Sensi, Marialuisa

AU - Fossati, Giuseppe

PY - 1985

Y1 - 1985

N2 - Experimental tumors may express cell surface antigens which cross-react with alloantigens of normal allogeneic tissues1. These may be H-2 or non-H-2 histocompatibility antigens and differentiation antigens1-3. Because of this cross-reactivity animals immunized with allogeneic normal tissues bearing determinants shared by a syngeneic transplantable tumor acquire resistance to the tumor in vivo and lymphocytes specifically cytotoxic to syngeneic tumor cells in vitro. However, in similar experiments tumor cells which did not express detectable amounts of cross-reacting antigens were also rejected in syngeneic animals (mouse and rat) immunized with normal allogeneic tissues4,5. In this instance the mechanism of antitumor rejection could not be clearly established5. In other investigations allostimulation of the mouse lymphocytes in vitro generated cells cytotoxic against syngeneic tumor cells and allostimulation of human lymphocytes generated cells which killed autologous tumor cells6-10. The mechanisms underlying these phenomena differ in detail but in each case the end result is the production of tumor-restricted cytotoxic cells. Here Giorgio Parmiani and his colleagues review these investigations and discuss the possible clinical utility of cytotoxic cells generated in this way.

AB - Experimental tumors may express cell surface antigens which cross-react with alloantigens of normal allogeneic tissues1. These may be H-2 or non-H-2 histocompatibility antigens and differentiation antigens1-3. Because of this cross-reactivity animals immunized with allogeneic normal tissues bearing determinants shared by a syngeneic transplantable tumor acquire resistance to the tumor in vivo and lymphocytes specifically cytotoxic to syngeneic tumor cells in vitro. However, in similar experiments tumor cells which did not express detectable amounts of cross-reacting antigens were also rejected in syngeneic animals (mouse and rat) immunized with normal allogeneic tissues4,5. In this instance the mechanism of antitumor rejection could not be clearly established5. In other investigations allostimulation of the mouse lymphocytes in vitro generated cells cytotoxic against syngeneic tumor cells and allostimulation of human lymphocytes generated cells which killed autologous tumor cells6-10. The mechanisms underlying these phenomena differ in detail but in each case the end result is the production of tumor-restricted cytotoxic cells. Here Giorgio Parmiani and his colleagues review these investigations and discuss the possible clinical utility of cytotoxic cells generated in this way.

UR - http://www.scopus.com/inward/record.url?scp=46549095183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46549095183&partnerID=8YFLogxK

U2 - 10.1016/0167-5699(85)90037-4

DO - 10.1016/0167-5699(85)90037-4

M3 - Article

AN - SCOPUS:46549095183

VL - 6

SP - 215

EP - 218

JO - Immunology Today

JF - Immunology Today

SN - 0167-5699

IS - 7

ER -